U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849544) titled 'Phase II Trial to Investigate the Safety and Efficacy of Three Dosing Regimens of OTL78 Injection' on Feb. 22.
Brief Summary: This study is being done to compare how well Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging may improve the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer Surgery
Prostate Cancer Metastatic Disease
Intervention:
DRUG: 0.03mg/kg ZOPOCIANINE given day of surgery
A sing...